ClinConnect ClinConnect Logo
Search / Trial NCT00376298

Urology Database to Evaluate Clinical Information and Improve Patient Care.

Launched by KENNETH PETERS, MD · Sep 13, 2006

Trial Information

Current as of April 25, 2025

Completed

Keywords

Incontinence Prostate Cancer Interstitial Cystitis

ClinConnect Summary

The current study population will include all patients having had a radical prostatectomy for the treatment of prostate cancer, surgical prolapse repair as well as patients having had InterStim sacral nerve stimulator implantation. The database will house data extracted from the medical records. Patient demographics, and preoperative, intra-operative, postoperative, and follow-up clinical data will be collected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients undergoing radical prostatectomy, pelvic organ prolapse repair and neurostimulator (Interstim) implantation at William Beaumont Hospital beginning January 1, 1998, as well as other urology patients as research questions are identified. Only patients who have accepted William Beaumont Hospital's Privacy Notices will be included in the database.
  • Exclusion Criteria:
  • Patients not acknowledging acceptance of William Beaumont Hospital's Privacy Notices.

Trial Officials

Kenneth Peters, MD

Principal Investigator

William Beaumont Hospitals

About Kenneth Peters, Md

Dr. Kenneth Peters is a distinguished clinical trial sponsor with extensive expertise in advancing medical research and innovative treatments. With a strong background in patient care and clinical methodologies, Dr. Peters is committed to enhancing therapeutic outcomes through rigorous trial design and ethical practices. His leadership in clinical studies spans multiple therapeutic areas, fostering collaboration among multidisciplinary teams to ensure the highest standards of scientific integrity and patient safety. Dr. Peters is dedicated to translating research findings into effective healthcare solutions that address unmet medical needs.

Locations

Royal Oak, Michigan, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials